Overview

Linezolid Plus Standard of Care

Status:
NOT_YET_RECRUITING
Trial end date:
2028-10-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to assess whether targeting virulence factors by administering linezolid in addition to standard antibiotic treatment improves outcomes in patients with Staphylococcus aureus bacteraemia.
Phase:
NA
Details
Lead Sponsor:
University Hospital, Basel, Switzerland
Collaborator:
Swiss National Science Foundation
Treatments:
Linezolid